Strength

Significant strength improvements are within reach.

ExaStim has been clinically proven to help people with spinal cord injuries build strength. Patients with complete and incomplete spinal cord injuries saw meaningful strength improvements within 8 weeks of therapy that were sustained even after therapy ended.

*Results from the ASPIRE Study.


Performance/Satisfaction

ExaStim makes everyday tasks easier.

ExaStim makes everyday tasks like bathing, grooming and eating easier, making it possible for people with spinal cord injuries to live more independently. Results from ANEUVO clinical studies show lasting impacts that go beyond treatment:

8 out of 10 patients continue to experience improved ability to manage everyday life tasks, even after therapy ends.*

*Results from the ASPIRE Study.

DOWNLOAD CASE STUDY

Function

Real functional improvement. Real-life benefits.

What if you could achieve two times greater functional improvements- without surgery? Patients with chronic, traumatic spinal cord injuries who received ExaStim therapy demonstrated 2x greater functional improvementthan those who did not receive ExaStim therapy.

*Results from the ASPIRE Study.

DOWNLOAD CASE STUDY


 

Dexterity

Improved dexterity is in your hands.

What could improved hand dexterity mean for you? Results from ANEUVO clinical studies show 85% of patients experienced an improvement in dexterity of one or both hands that was sustained even 4 weeks after cessation of treatment.* Building dexterity can make it easier to manage daily tasks like writing, dressing and housekeeping—leading to greater independence.

*Results from the ASPIRE Study. According to performance on 9-Hole Peg Test.

Data based on analysis of Modified Intent-to-Treat (MITT), treatment as administered population.

Sensory

Results you can feel

Touch sensation in the hand is important for preventing injuries, performing daily tasks, and feeling connected. Clinical studies have shown improvement in touch sensation for people who use ExaStim: At the completion of treatment, clinical evaluations showed a measurable increase in light touch sensation of the hand.

Participants receiving ExaStim therapy showed an average improvement of 1.1 points in light touch sensation of the hand alone.

*Results from ASPIRE Study. According to ISNCSCI light touch subscores of C6-T1.

Satisfaction

Therapy that fits your life

We’re excited about the results of our clinical trials–and our patients are, too.

87% of patients were satisfied with their experience using ExaStim.

26 of 30 patients ranked their experience with ExaStim as 5 or greater.

*Results from ASPIRE Home Study.

96% of patients reported feeling confident in using the ExaStim Stimulation System in their home.

29 of 30 patients ranked their confidence in using ExaStim at home as 5 or greater.

*Results from ASPIRE Home Study.

Safety

Clinically Demonstrated Safety & Effectiveness

You can feel confident that ExaStim is a safe and effective therapy option. ExaStim was shown to be safe in clinical studies, with no serious side effects caused by device use.

Support for clinicians.
Peace of mind for their patients.

Contact Us

The Company

At ANEUVO, we share a common goal: to help restore functional independence, improve quality of life, and create a healthier, more equitable world for people living with disabling diseases and conditions.

Learn More

Schedule a consultation and explore the benefits of ExaStim® Therapy.

Schedule
Wavelengths

Real people. Real results.

Read what clinicians and people with lived experience have to say about ANEUVO and the ExaStim Stimulation System.

“I feel slightly stronger and my range of motion might be a little bit better. Like I feel like I can reach an itch on my head a bit better. My ability to pick up small objects is sort of improved too. I can’t pinch, but tendonesis may be stronger.”

Kyle K., Patient

“Overall, I loved using the device. It provided me with such great feedback and input with stimulation, and I thought my hand function improved greatly!”

Larry B., Patient

“My experience with the ExaStim device was extraordinary. After four weeks of use, I saw a significant increase in my ability to manipulate objects with my hands that hadn’t been present before. Just as important, in the short period of time I participated in the study I realized a marked improvement in sensation.

Jamison B., Patient

“Overall, I highly recommend patients try ExaStim. It takes a little getting used to, but the results were incredible after using it for only 4 weeks. As a quadriplegic, the most life-changing result would be to regain any amount of hand/wrist function — and ANEUVO made that a reality! I look forward to using the device again in the future!”

Sean H., Patient

“Having a highlevel SCI, my son’s deepest desire has not been to walk but rather to have functioning hands again. In only 4 weeks, ExaStim has allowed him to hold and pour a drink into his own mouth!” 

Anonymous, Caregiver

If this brought more independence in as little as one month, it is extremely exciting to think of what it will do with prolonged use! Thank you, ANEUVO for restoring hope and some function!

Stephanie J., Caregiver

“As a neuro physical therapist specializing in spinal cord injury rehabilitation, I highly recommend the ExaStim Trans Spinal Stimulation (TSS) device by ANEUVO as a cutting-edge adjunct to activity-based therapy.”

Sakina V., Therapist

“After only a month using this TSS for an average of 3 times a week at an hour each, the ExaStim has given me the independence to pick up a cup and drink without a straw for the first time in years!”

Sean H., Patient

“It alleviated that warm-up need when doing activities. Because of the sensory aspect, I felt the motion was more fluid. I may not have been able to do more, but the movements I could do were more fluid. One of the best things about doing this at home was helping my family cook food with the stimulation on — I was able to cut up beets and put them on the slicer.” 

Tony S., Patient

“ANEUVO offers something unique to chronic cervical spinal sufferers. It offers hope. The device and the stimulation provided a spark that started to make certain movements possible and other movements easier. Since its transcutaneous, it’s non-invasive and there’s really no reason to not at least try the stim.” 

Dan S., Patient

ANEUVO in the News

ANEUVO has been featured by leading news networks, business and health podcasts, and science and research conferences around the world. Learn more about our company, our technology, and individuals’ experiences with transcutaneous spinal stimulation and the ExaStim Stimulation System in the stories below.

ANEUVO Receives FDA Clearance for ExaStim<sup><sup>®</sup></sup>

ANEUVO Receives FDA Clearance for ExaStim®

U.S. market entry furthers global mission for accessible clinical and at-home non-invasive neuromodulation therapy Los Angeles, CA, April 16, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a...

Read more
Investigational therapy helps Easthampton man regain movement after spinal cord injury

Investigational therapy helps Easthampton man regain movement after spinal cord injury

EASTHAMPTON, MA (WGGB/WSHM) -- Nearly a decade after a training ride crash left him with a spinal cord injury, an Easthampton man is regaining function...

Read more
ANEUVO Secures Series C Funding to Strengthen ExaStim<sup>®</sup> Regulatory Readiness and Global Operational Scale

ANEUVO Secures Series C Funding to Strengthen ExaStim® Regulatory Readiness and Global Operational Scale

Proceeds to support manufacturing growth, regulatory advancement, and disciplined commercialization expansion Los Angeles, CA, March 05, 2026 (GLOBE NEWSWIRE) -- ANEUVO, a medical technology company...

Read more
ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim<sup>®</sup> Neuromodulation Technology

ANEUVO Recognized with Taiwan’s 22nd National Innovation Award for ExaStim® Neuromodulation Technology

Honor highlights international startup advancing non-invasive rehabilitation technology for people living with chronic spinal cord injury Los Angeles, CA, Feb. 11, 2026 (GLOBE NEWSWIRE) --...

Read more
ANEUVO Showcases ExaStim<sup>®</sup> Therapy At RehaCare 2025 and ISCoS 2025

ANEUVO Showcases ExaStim® Therapy At RehaCare 2025 and ISCoS 2025

The first MDR-Approved Non-Invasive Spinal Stimulation System in Europe Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two...

Read more
ANEUVO’s ExaStim<sup>®</sup> Earns CE Mark Certification

ANEUVO’s ExaStim® Earns CE Mark Certification

Key Milestone Signals Readiness for European Market Entry and Commitment to Quality Los Angeles, CA, April 09, 2025 (GLOBE NEWSWIRE) -- ANEUVO, a pioneer in...

Read more
ANEUVO Launches ASPIRE<sup>™</sup> Home Study to Evaluate Home Use of ExaStim<sup>®</sup>

ANEUVO Launches ASPIRE Home Study to Evaluate Home Use of ExaStim®

This new phase of clinical research will test the safety and feasibility of ANEUVO’s non-invasive therapy for future use by individuals living with chronic spinal...

Read more
Massachusetts skier faces uphill climb after ‘worst possible injury imaginable’

Massachusetts skier faces uphill climb after ‘worst possible injury imaginable’

BOSTON — Michael Feinberg has had three years to think about the moment on the ski slope that changed his life forever. “It’s horrifying,” he...

Read more
View More

[1] Christopher & Dana Reeve Foundation. (n.d.). Statistics about paralysis. Retrieved from https://www.christopherreeve.org/todays-care/paralysis-help-overview/stats-about-paralysis

[2] Taylor C, McHugh C, Mockler D, Minogue C, Reilly RB, Fleming N. (2021) Transcutaneous spinal cord stimulation and motor responses in individuals with spinal cord injury: A methodological review. PLoS One. 2021 Nov 18;16(11):e0260166.